Sagility jumps on acquiring CareSeed to strengthen healthcare quality
iliis currently trading at Rs. 39.92, up by 0.68 points or 1.73% from its previous closing of Rs. 39.24 on the BSE.
The scrip opened at Rs. 40.60 and has touched a high and low of Rs. 40.66 and Rs. 39.75 respectively. So far 362444 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 57.90 on 30-Oct-2025 and a 52 week low of Rs. 35.82 on 23-Mar-2026.
Last one week high and low of the scrip stood at Rs. 40.60 and Rs. 38.90 respectively. The current market cap of the company is Rs. 18,706.59 crore.
The promoters holding in the company stood at 50.95%, while Institutions and Non-Institutions held 32.31% and 16.74% respectively.
Sagility has acquired CareSeed, a U.S.-based healthcare analytics company specializing in NCQA-certified HEDIS quality reporting, medical record review, chart abstraction, and regulatory analytics for health plans. The acquisition represents a strategic expansion of Sagility’s healthcare quality and Stars capabilities and advances the company’s broader vision of moving health plans beyond retrospective HEDIS reporting toward integrated, member-level quality orchestration.
By combining CareSeed’s technology with Sagility’s healthcare operations, clinical services, and AI-led transformation capabilities, Sagility will deliver an end-to-end quality operations continuum. The combined offering will support health plans across the full quality lifecycle - from HEDIS abstraction and reporting to prospective gap closure, provider engagement, care coordination, and continuous performance monitoring.
CareSeed’s Forecast platform provides NCQA-certified HEDIS reporting and quality analytics, while Harvest delivers cloud-based medical record review, chart abstraction, and supplemental data capture capabilities. Together, these platforms create a modern foundation for quality operations transformation and integrated care continuum management. The acquisition strengthens Sagility’s position in the mid-market payer segment while expanding opportunities to bring scalable quality and Stars solutions to larger national health plans.
